InvestorsHub Logo
Followers 66
Posts 12688
Boards Moderated 0
Alias Born 06/03/2015

Re: crescentmotor post# 448936

Tuesday, 01/23/2024 5:01:08 PM

Tuesday, January 23, 2024 5:01:08 PM

Post# of 459815
Nice FUD spin...

The fact that Missling recently pivoted to 3-71 in schizophrenia for the next AVXL clinical trial may have been a "tell" that AVXL's focus solely on 2-73 has shifted


It's not a pivot at all; it's a continuation of planned trials for their follow-on drug 3-71 (P1 happened many months ago). They are managing an entire platform of SigmaCeptor drugs with 2-73 leading the way and likely to be approved later this year. Not hard of comprehend, really.

Missling already explained they were waiting on Excellence... for voucher purposes.

So far as I know, there was nothing to prevent AVXL from filing a U.S. NDA last year


Hmmm... Why do people dismiss Missling's comments or forget what was said?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News